Fluzone Hd Tiv Sh 2026 Injection, Suspension
Product Images NDC 49281-016

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fluzone Hd Tiv Sh 2026 (NDC 49281-016). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi Vaccines Us Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (0.5 mL Syringe Label)

This is a medication package label for an Influenza Vaccine 2025 called Fluzone®High-Dose Formula. It is intended for individuals aged 65 years and older in the Southern Hemisphere. This vaccine is preservative-free and comes in a single-dose of 0.5mL for intramuscular use. The manufacturer is Sanofi Pasteur Inc.*

FDA Label Image

Principal Display Panel (0.5 mL 10 Syringe Carton)

This text provides detailed information about the Fluzone High-Dose Influenza Vaccine formulated for the 2025 season in the Southern Hemisphere. It comes in 10 single-dose prefilled syringes and should be stored between 2 to 8°C. The vaccine is produced from influenza viruses grown in chicken eggs and inactivated with formaldehyde. It contains 180 micrograms of hemagglutinin per 0.5 mL dose and is standardized as per USPHS requirements. The vaccine includes strains representative of H1N1, H3N2, and B/Victoria lineage, with no preservatives or natural rubber latex. Not-made contains 'Titon X-100'.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.